Deepa M. Rich is a partner in Goodwin’s Life Sciences group. She focuses her practice on general securities and corporate law, with an emphasis on representing private and public companies in the life sciences and healthcare industries. Ms. Rich counsels companies throughout their lifecycle and guides them from startup through IPO or acquisitions. She also handles regulatory matters involving the U.S. Securities and Exchange Commission and Nasdaq. In addition to company representation, Ms. Rich regularly represents venture capital funds with respect to their investments in companies in the life sciences and healthcare industries.
Prior to joining Goodwin in 2019, Ms. Rich has practiced in the life sciences groups at other law firms.
Prior to attending law school, Ms. Rich was a commodity manager at 3Com and Palm Inc. During law school, she was an extern to the presiding judge in the California Sixth District Court of Appeal. She was also an extern to Judge Richard G. Seeborg in the U.S. District Court for the Northern District of California.
Ms. Rich has been recognized by the Daily Journal as a Top Healthcare Lawyer in 2020.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.